APA (7th ed.) Citation

Fasano, M., Pirozzi, M., De Falco, V., Miceli, C. C., Farese, S., Zotta, A., . . . Addeo, R. (2024). Temozolomide based treatment in glioblastoma: 6 vs. 12 months. Oncology Letters, 28(3), N.PAG. https://doi.org/10.3892/ol.2024.14551

Chicago Style (17th ed.) Citation

Fasano, Morena, et al. "Temozolomide Based Treatment in Glioblastoma: 6 Vs. 12 Months." Oncology Letters 28, no. 3 (2024): N.PAG. https://doi.org/10.3892/ol.2024.14551.

MLA (9th ed.) Citation

Fasano, Morena, et al. "Temozolomide Based Treatment in Glioblastoma: 6 Vs. 12 Months." Oncology Letters, vol. 28, no. 3, 2024, p. N.PAG, https://doi.org/10.3892/ol.2024.14551.